SenzaGen is proud to sponsor, exhibit and present at MVIC’s Symposium, MVIS, 2018 Date: Wednesday the 3rd of October – Thursday the 4th of October 2018 Time: Day 1: 09.00–18.00. Day 2: 09.00–13.00 Place: Medicon Village, Lund, Sweden Presentation, Day 2: 09.25–09.50 , Predictive Respiratory Toxicology with the GARD In-Vitro Testing Platform, Dr Henrik Johansson, SenzaGen […]

SenzaGen is proud to sponsor, exhibit and present poster at the ESTIV conference, 2018. The conference emphasis will be specifically on how new technologies can strengthen the interpretation and application of in vitro methods in toxicological research and risk assessment. The ESTIV conference will be the official launch of the new GARDair, the first in vitro […]

SenzaGen is present at the Medical Design & Manufacturing (MD&M) Minneapolis The MD&M Minneapolis Conference is the region's largest educational offering of its kind, taking place in North America's second largest hub for medical device innovation — the Midwest. This year's conference lineup features a curated roster of speakers with deeply technical expertise in everything from product […]

SenzaGen is participating at The American College of Toxicology 2018 Annual Meeting that will be held Nov. 4-7 in West Palm Beach. This year’s meeting will feature lectures, poster sessions, and other events for today’s toxicologists to network with each other and hone their skills. For more information on ACT 2018, please visit www.actox.org.

24th annual conference

SenzaGen is participating at the Biocompatibility for Medical Devices, Barcelona. Updates and changes to the ISO 10993 standards, regulatory updates and case studies of how to use ISO 10993 for evaluation of Medical Devices ISO 10993: ARE YOU BIOCOMPATIBLE? Risk Mitigation. Chemical Characterisation. Practical Implementation.   Meet our Medical Device experts Rose-Marie Jenvert and Joshua Schmidt  […]

En 2018, le congrès annuel de la SFT a lieu à Lille, les 27 et 28 novembre, espace Jeanne de Flandre (Lille Grand Palais). Poster GARD® – in vitro safety assessment of skin and respiratory sensitizers using a genomics-based platform Meet Anna Cherouvrier Hansson at the conference. To book a meeting, please email: anna.c.hansson (at) […]

Dr Andy Forreryd is one of three speakers at the Human Safety Seminar organised by Eurofins BioPharma Product Testing Munich where he is to present the GARD platform for skin and respiratory sensitization  Topics for the seminar:  In vitro Methods to test for Endocrine Disrupting Properties   In vitro Skin sensitization – Challenges to Overcome  Eye Irritation ex vivo and in vitro methods – Current status  GARD […]

In vitro testing for Respiratory Sensitizers using a genomic biomarker signature and the GARD™ technology platform A seminar given on two occasions, this one targeted for the EUROPEAN time zone The presentation will give insight into the latest in vitro technology for identifying respiratory sensitizers using human dendritic-like cell lines and genomics.  A thorough explanation of the […]

In vitro testing for Respiratory Sensitizers using a genomic biomarker signature and the GARD™ technology platform A seminar given on two occasion. This one targeted forthe US audience at 13:00 EST  (19:00 CET) The presentation will give insight into the latest in vitro technology for identifying respiratory sensitizers using human dendritic-like cell lines and genomics.  […]